Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients
Colt A. Egelston, Christian Avalos, Travis Y. Tu, et al.
JCI Insight (2019) Vol. 4, Iss. 19
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
Chirag Krishna, Renzo G. DiNatale, Fengshen Kuo, et al.
Cancer Cell (2021) Vol. 39, Iss. 5, pp. 662-677.e6
Open Access | Times Cited: 279
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
Feng Li, Caichen Li, Xiuyu Cai, et al.
EClinicalMedicine (2021) Vol. 41, pp. 101134-101134
Open Access | Times Cited: 252
Promises and challenges of adoptive T-cell therapies for solid tumours
Matteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.
British Journal of Cancer (2021) Vol. 124, Iss. 11, pp. 1759-1776
Open Access | Times Cited: 200
The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer
Stephanie L. Goff, David N. Danforth
Clinical Breast Cancer (2020) Vol. 21, Iss. 1, pp. e63-e73
Open Access | Times Cited: 153
Tissue-resident memory T cells in tumor immunity and immunotherapy
Karolina Okła, Donna L. Färber, Weiping Zou
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 4
Open Access | Times Cited: 147
Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells
Ilkka Liikanen, Colette Lauhan, Sara Quon, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 7
Open Access | Times Cited: 109
Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma
Nekisa Zakeri, Andrew Hall, Leo Swadling, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 87
Localization, tissue biology and T cell state — implications for cancer immunotherapy
Jason M. Schenkel, Kristen E. Pauken
Nature reviews. Immunology (2023) Vol. 23, Iss. 12, pp. 807-823
Open Access | Times Cited: 62
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer
Giacomo Oliveira, Ann Marie Egloff, Alexander B. Afeyan, et al.
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 44
Memory CD8+ T cell responses to cancer
Jichang Han, Nikhil Khatwani, Tyler G. Searles, et al.
Seminars in Immunology (2020) Vol. 49, pp. 101435-101435
Open Access | Times Cited: 135
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
Jasneet Kaur Khalsa, Nina Cheng, Joshua Keegan, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 120
Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer
Molly A. Nelson, Worapol Ngamcherdtrakul, Shiuh‐Wen Luoh, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 2, pp. 519-536
Open Access | Times Cited: 88
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals
Francesco Manfredi, Beatrice Claudia Cianciotti, Alessia Potenza, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 87
Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition
Laura C. D. Pomatto-Watson, Monica Bodogai, Oye Bosompra, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 84
CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer
Paulino Tallón de Lara, Héctor Castañón, Marijne Vermeer, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 64
Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell–Cell Interactions That Predict Immunotherapy Response
Asier Antoranz, Yannick Van Herck, Maddalena M. Bolognesi, et al.
Cancer Research (2022) Vol. 82, Iss. 18, pp. 3275-3290
Open Access | Times Cited: 44
The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors
Anna Tosi, Beatrice Parisatto, Anna Menegaldo, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 44
CD39 + tissue-resident memory CD8 + T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer
Yong Joon Lee, Jee Ye Kim, Seung Hyuck Jeon, et al.
Science Immunology (2022) Vol. 7, Iss. 74
Closed Access | Times Cited: 43
An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes
Abhinav Jaiswal, Akanksha Verma, Ruth Dannenfelser, et al.
Cancer Cell (2022) Vol. 40, Iss. 5, pp. 524-544.e5
Open Access | Times Cited: 41
Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy
Isabelle Damei, Tatiana Trickovic, Fathia Mami‐Chouaib, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer
Tingyao Dou, Jing Li, Yaochen Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Breast Cancer Heterogeneity and Response to Novel Therapeutics
Mariona Baliu‐Piqué, Atanasio Pandiella, Alberto Ocaña
Cancers (2020) Vol. 12, Iss. 11, pp. 3271-3271
Open Access | Times Cited: 57
LLT1-CD161 Interaction in Cancer: Promises and Challenges
Véronique M. Braud, Aïda Meghraoui-Kheddar, Roxane Elaldi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment
Sanjay Mishra, Manish Charan, Rajni Kant Shukla, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 35
Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer
Colt A. Egelston, Weihua Guo, Jiayi Tan, et al.
JCI Insight (2022) Vol. 7, Iss. 3
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top